U.S. National Institutes of Health
U.S. National Institutes of Health

IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2373123731Single Dose Escalation Study of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNo Results AvailableHead and Neck NeoplasmsDrug: bivatuzumab mertansinehttps://ClinicalTrials.gov/show/NCT02254018
2373223732Single Dose Escalation Study of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Metastatic Breast CancerCompletedNo Results AvailableBreast NeoplasmsDrug: bivatuzumab mertansinehttps://ClinicalTrials.gov/show/NCT02254005
2373323733Study of the Safety and Tolerability of Urelumab Administered in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkins LymphomaRecruitingNo Results AvailableAdvanced Solid Tumors|Advanced B-cell NHLBiological: Urelumab|Biological: Nivolumabhttps://ClinicalTrials.gov/show/NCT02253992
2373423734Comparison of VivaSightTM Double Lumen Tube With a Conventional Double Lumen TubeCompletedNo Results AvailableEndotracheal Intubation|Airway Management|One Lung VentilationDevice: Standard double lumen tube|Device: VivaSight double lumen tubehttps://ClinicalTrials.gov/show/NCT02253979
2373523735Preoperative Intraarticular Injection of Methylprednisolone in Patients Scheduled for Total Knee-arthroplastyRecruitingNo Results AvailableKnee Joint Osteoarthrosis|Hyperalgesia|Severe Movement Related PainDrug: Methylprednisoloneacetate|Drug: Lidocaine|Other: sodium chloridehttps://ClinicalTrials.gov/show/NCT02253966
2373623736Pharmacokinetics of Single Doses of BILR 355 BS Given With Ritonavir in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BILR 355 BS, D1|Drug: BILR 355 BS, D2|Drug: BILR 355 BS, D3|Drug: BILR 355 BS, D4|Drug: BILR 355 BS, D5|Drug: BILR 355 BS, D6|Drug: BILR 355 BS, D7|Drug: BILR 355 BS, D8|Drug: BILR 355 BS, D10|Drug: Placebo|Other: high-fat breakfast|Drug: Ritonavirhttps://ClinicalTrials.gov/show/NCT02253953
2373723737Pharmacokinetics and Safety of BILR 355 in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BILR 355 - Treatment A (current tablet formulation)|Drug: BILR 355 - Treatment B (new tablet formulation)|Drug: BILR 355 - Treatment C (new capsule formulation)|Drug: BILR 355 - Treatment D (current tablet formulation)|Drug: BILR 355 - Treatment E (new capsule formulation)|Drug: Ritonavirhttps://ClinicalTrials.gov/show/NCT02253940
2373823738Dose Escalation Study of Pharmacokinetics, Safety and Tolerability After Single Dose Administration of BILR 355 (SDS) Plus Low-dose Ritonavir in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: BILR 355 - D1|Drug: BILR 355 - D2|Drug: BILR 355 - D3|Drug: BILR 355 - D4|Drug: Ritonavir|Other: high fat breakfasthttps://ClinicalTrials.gov/show/NCT02253927
2373923739Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of BILR 355 BS Plus Low Dose Ritonavir in HIV-uninfected Male VolunteersCompletedNo Results AvailableHealthyDrug: BILR 355 BS, solution|Drug: BILR 355 BS, tablet|Drug: Ritonavir|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02253914
2374023740Pharmacokinetic Interaction Between TRUVADAâ„¢ and BILR 355 BS Plus Ritonavir in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: BILR 355 BS|Drug: Ritonavir|Drug: TRUVADAhttps://ClinicalTrials.gov/show/NCT02253901
2374123741Bioequivalence Study of Tipranavir Stored at Controlled Temperature Compared With Tipranavir Stored at Controlled Refrigerated Conditions, Orally Co-administered With Ritonavir in Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: TPV - Room condition|Drug: TPV - Refrigerated conditions|Drug: Ritonavir (RTV)https://ClinicalTrials.gov/show/NCT02253888
2374223742Study to Determine the Effects of Multiple-dose Omeprazole on the Single-dose Pharmacokinetics of Tipranavir (TPV) Coadministered With Ritonavir (RTV) in Healthy Adult VolunteersCompletedNo Results AvailableHealthyDrug: Tipranavir (TPV)|Drug: Ritonavir|Drug: Omeprazolehttps://ClinicalTrials.gov/show/NCT02253875
2374323743Pharmacokinetic of Tadalafil Co-administered With Tipranavir/Ritonavir to Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: Tadalafil|Drug: Tipranavir|Drug: Ritonavirhttps://ClinicalTrials.gov/show/NCT02253862
2374423744Effects of TPV/r on the Pharmacokinetics of Carbamazepine in Healthy Adult VolunteersCompletedNo Results AvailableHealthyDrug: Carbamazepine|Drug: Tipranavir|Drug: Ritonavirhttps://ClinicalTrials.gov/show/NCT02253849
2374523745Pharmacokinetic Study in Healthy Adult Volunteers to Assess the Interactions Between Steady-State Tipranavir and Atazanavir in the Presence of RitonavirCompletedNo Results AvailableHealthyDrug: Tipranavir|Drug: Ritonavir|Drug: Atazanavirhttps://ClinicalTrials.gov/show/NCT02253836
2374623746Multiple Dose Comparison of the Effect of Two Dose Combinations of Tipranavir/Ritonavir (TPV/RTV), on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) in Healthy Adult VolunteersCompletedNo Results AvailableHealthyDrug: EFV|Drug: TPV/RTV - low dose|Drug: TPV/RTV - high dosehttps://ClinicalTrials.gov/show/NCT02253823
2374723747Efficacy of Tranexamic Acid for Reducing Blood Loss and Blood Transfusion After Periacetabular OsteotomyEnrolling by invitationNo Results AvailableDysplasia, Congenital HipDrug: Tranexamic Acid|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02253810
2374823748Pharmacokinetics of Tipranavir/Ritonavir and Its Metabolites in Healthy Male SubjectsCompletedNo Results AvailableHealthyDrug: 14C-Tipranavir|Drug: Tipranavir|Drug: Ritonavirhttps://ClinicalTrials.gov/show/NCT02253797
2374923749Comparison Between Perineural and Systemic Effect of Dexamethasone as an Adjuvant for Prolongation of Four Nerve Blocks With Bupivacaine in Total Knee ArthroplastyNot yet recruitingNo Results AvailableAnalgesia|Pain, PostoperativeDrug: Dexamethasone|Drug: Bupivacainehttps://ClinicalTrials.gov/show/NCT02253784
2375023750Shockwave Therapy for Acute Low Back PainRecruitingNo Results AvailableAcute Low Back Pain (Low Back Pain for Less Than 3 Months)Device: shockwave therapyhttps://ClinicalTrials.gov/show/NCT02253771
2375123751Arousal Pathways and Emergence From SedationNot yet recruitingNo Results AvailableAnesthesiaDrug: Propofolhttps://ClinicalTrials.gov/show/NCT02253758
2375223752Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)CompletedNo Results AvailableADHDDrug: V81444|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02253745
2375323753Skeletal Muscle as a Mediator of Exercise Induced Effects on Metabolism & Cognitive Function: Role for Myokines & miRNAsRecruitingNo Results AvailableMild Cognitive Impairment|Alzheimer Disease|Parkinson Disease|Healthy VolunteersBehavioral: 3 months exercise intervention programhttps://ClinicalTrials.gov/show/NCT02253732
2375423754Cervical Cancer Screening in HIV Positive and Negative Women in CambodiaNot yet recruitingNo Results AvailableCervical Neoplasia|Cervical CancerProcedure: cryotherapy, further biopsy, LEEP, surgery as indicatedhttps://ClinicalTrials.gov/show/NCT02253719
2375523755Oxygen Supplementation During Bronchoscopy: High Flow Versus Low Flow OxygenNot yet recruitingNo Results AvailableHypoxiaDevice: High flow nasal oxygen supplementation|Device: low flow nasal oxygen supplementationhttps://ClinicalTrials.gov/show/NCT02253706
2375623756Exploratory Pilot Study of Physical Activity Monitoring in Adult Patients With Haemophilia A by Means of AccelerometryRecruitingNo Results AvailableHemophilia A, Congenitalhttps://ClinicalTrials.gov/show/NCT02253693
2375723757The Use of Compression Bandages in Total Knee Replacement SurgeryActive, not recruitingNo Results AvailableOsteoarthritisProcedure: Actico, short-stretch, inelastic dressinghttps://ClinicalTrials.gov/show/NCT02253680
2375823758Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease PatientsNot yet recruitingNo Results AvailableLung Disease|Acute Respiratory Distress SyndromeDevice: HFONC|Device: Conventional oxygen therapyhttps://ClinicalTrials.gov/show/NCT02253667
2375923759If Alternate Dosing is Superior at Maintaining Hb Between 10.0 to 11.0 g/dL in CKD Subjects on HD vs the Current USPIRecruitingNo Results AvailableRenal Insufficiency, Chronic|Anemia|Renal Dialysis|Erythrocyte TransfusionDrug: Epoetin alfahttps://ClinicalTrials.gov/show/NCT02253654
2376023760The STRENGTH Study: Shapely Sisters Targeting Realistic Exercise and Nutrition Goals Through Healthy HabitsCompletedNo Results AvailableObesityBehavioral: Standard Weight Loss Intervention|Behavioral: Stress-Focused Weight Loss Interventionhttps://ClinicalTrials.gov/show/NCT02253641

* Görseller ve İçerik tekif hakkına sahip olabilir